Sign In
Buy BIXT
$0.0238
+0.0020 (+8.95%)
At Close: Jul 31, 2026
Bioxytran Interview at the Emerging Growth Conference
09:00am, Wednesday, 04'th Oct 2023
BOSTON, MASSACHUSETTS, Oct. 04, 2023 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat COVID-
Bioxytran Announces Broad Spectrum Antiviral Activity Highlighted in ProLectin-M
09:41am, Thursday, 14'th Sep 2023
BOSTON, MASSACHUSETTS, Sept. 14, 2023 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (BIXT), (the “Company”), a clinical stage biotechnology company developing oral drugs to treat COVID-19 and other viral di
Bioxytran Announces FDA Clearance of its IND Application for ProLectin-M in Clinical Trials
09:00am, Thursday, 24'th Aug 2023
BOSTON, MASSACHUSETTS, Aug. 24, 2023 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (BIXT), (the “Company”), a clinical stage biotechnology company developing oral drugs to treat COVID-19 and other viral dis
Bioxytran Initiates a Registrational Trial of Oral ProLectin-M for Mild to Moderate COVID-19 Patients
07:00am, Tuesday, 08'th Aug 2023
BOSTON, MASSACHUSETTS, Aug. 08, 2023 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (BIXT), (the “Company”), a clinical stage biotechnology company developing oral drugs to treat COVID-19 and other viral dis
Bioxytran Names Leslie Ajayi as Interim CMO and Head of the Medical Advisory Board
07:00am, Monday, 31'st Jul 2023
BOSTON, MASSACHUSETTS, July 31, 2023 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (BIXT), (the “Company”), a clinical stage biotechnology company developing oral drugs to treat COVID-19 and other viral dis
Bioxytran's positive Phase 2 trial results featured in ‘Vaccines' peer-reviewed journal
04:04pm, Wednesday, 29'th Mar 2023
Bioxytran said positive top-line safety and efficacy results from the company's randomized, placebo-controlled Phase 2 clinical trial of its drug candidate Prolectin-M in 34 patients with mild-to-mod
Bioxytran Scientific Advisor Releases New Book on Brain Metabolism
07:30am, Tuesday, 25'th Oct 2022
The book contains all aspects of brain energy metabolism and other physiological functions related to Cortical Spreading Depression which is the essence of how the brain consumes oxygen. BOSTON, MASSA
